Detalhe da pesquisa
1.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992344
2.
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.
Blood
; 128(14): 1814-1820, 2016 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354719
3.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039078
4.
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.
Blood
; 135(22): 2000-2004, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181815
5.
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Blood
; 125(5): 856-9, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25634617
6.
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.
Blood
; 123(19): 2953-9, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652994
7.
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Haematologica
; 101(8): 959-67, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198719
8.
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.
Blood
; 119(19): 4467-75, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415752
9.
Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.
Haematologica
; 99(11): 1722-30, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085355
10.
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.
Blood Adv
; 8(2): 407-415, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113470
11.
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases.
Blood
; 118(11): 3088-95, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791422
12.
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.
Haematologica
; 103(11): e541-e543, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794145
13.
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV.
Front Oncol
; 12: 1023015, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483037
14.
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.
Hemasphere
; 5(1): e510, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33364550
15.
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.
Oncoimmunology
; 10(1): 1975889, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-38283034
16.
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
Clin Cancer Res
; 26(6): 1507-1515, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919133
17.
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Haematol
; 5(3): e109-e116, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396091
18.
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.
Leukemia
; 36(12): 2912-2916, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274067
19.
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Clin Cancer Res
; 23(17): 5292-5301, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536306
20.
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.
Lancet Haematol
; 1(2): e74-84, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27030157